Case number 1:19-cv-01866
Boehringer Ingelheim International GmbH et al v. Lupin Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Oct 29, 2019 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:18-cv-01689-CFC-SRF. (fms) |
| Oct 29, 2019 | N/A | Remark (0) Docket Text: All papers shall be filed in C.A. No. 18-1689 (CFC) (consolidated). Associated Cases: 1:18-cv-01689-CFC-SRF et al.(fms) |
| Oct 29, 2019 | 11 | SO ORDERED (6) Docket Text: SO ORDERED, re (8 in 1:19-cv-01866-CFC, 8 in 1:19-cv-01865-CFC, 8 in 1:19-cv-01885-CFC, 8 in 1:19-cv-01864-CFC, 127 in 1:18-cv-01689-CFC-SRF, 9 in 1:19-cv-01862-CFC) Stipulation. The New Cases shall be consolidated with the Consolidated Action for all purposes, and all papers shall be filed in C.A. No. 18-1689 (CFC) (consolidated). See Stipulations for further details and deadlines. Signed by Judge Colm F. Connolly on 10/29/2019. Associated Cases: 1:18-cv-01689-CFC-SRF et al.(fms) |
| Oct 23, 2019 | N/A | Add Corporate Affiliates/Parents (0) Docket Text: Corporate Affiliates/Parents added per Disclosure Statement: identifying Other Affiliate Lupin Atlantis Holdings S.A., Other Affiliate Lupin Inc. for Lupin Pharmaceuticals, Inc.. (fms) |
| Oct 23, 2019 | 9 | Answer to Complaint (18) Docket Text: ANSWER to [1] Complaint, Affirmative Defenses and, COUNTERCLAIM against Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. by Lupin Ltd., Lupin Pharmaceuticals, Inc..(Phillips, John) |
| Oct 23, 2019 | 10 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Lupin Ltd. for Lupin Pharmaceuticals, Inc. filed by Lupin Pharmaceuticals, Inc.. (Phillips, John) |
| Oct 21, 2019 | 8 | Stipulation (6) Docket Text: STIPULATION for Consolidation by Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc., Zydus Pharmaceuticals (USA) Inc.. (Bilson, David) |
| Oct 10, 2019 | 6 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Boehringer Ingelheim International GmbH, Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc.. Lupin Ltd. served on 10/10/2019, answer due 10/31/2019. (Blumenfeld, Jack) |
| Oct 10, 2019 | 7 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Boehringer Ingelheim International GmbH, Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc.. Lupin Pharmaceuticals, Inc. served on 10/10/2019, answer due 10/31/2019. (Blumenfeld, Jack) |
| Oct 9, 2019 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:19-cv-01862-CFC, 1:19-cv-01864-CFC, 1:19-cv-01865-CFC, 1:19-cv-01866-CFC, 1:19-cv-01885-CFC (rjb) |
| Oct 4, 2019 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Lupin Ltd. on 10/4/2019; Lupin Pharmaceuticals, Inc. on 10/4/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (myr) |
| Oct 3, 2019 | 1 | Main Document (13) Docket Text: COMPLAINT filed against Lupin Ltd., Lupin Pharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-2746816.) - filed by Boehringer Ingelheim International GmbH, Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc.. (Attachments: # (1) Exhibit 1-2, # (2) Civil Cover Sheet)(myr) |
| Oct 3, 2019 | 1 | Exhibit 1-2 (94) |
| Oct 3, 2019 | 1 | Civil Cover Sheet (1) |
| Oct 3, 2019 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (myr) |
| Oct 3, 2019 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 8/27/2019. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 2/1/2022. (myr) |
| Oct 3, 2019 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,258,637 B2 ;9,949,998 B2. (myr) |
| Oct 3, 2019 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent C. H. Boehringer Sohn AG & Co. KG. for Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (myr) |
